Skip to main
INNV

INNV Stock Forecast & Price Target

INNV Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 0%
Sell 50%
Strong Sell 0%

Bulls say

InnovAge Holding is in a strong financial position with significant growth potential in the growing healthcare industry. With its unique approach to addressing key challenges facing the U.S. healthcare system and strong financial outlook for FY27, InnovAge Holding is well-positioned to continue providing high-quality, cost-effective care to high-cost seniors and potentially expand its reach to serve additional populations. The Company's recent impressive financial performance, focus on margin preservation for FY27, and potential for M&A opportunities make it an attractive stock for investors seeking exposure to the healthcare sector. However, risks associated with regulatory changes and state budget pressures should also be taken into consideration.

Bears say

InnovAge Holding is on track for success with its positive fourth-quarter results and strong fiscal year 2027 guidance, signaling significant growth potential in the upcoming years despite conservative assumptions. Under the leadership of CEO Patrick Blair and CFO Ben Adams, the company has implemented a PACE-specific EMR and focused on network management, utilization management, payment integrity, and specialist referrals to optimize operations and generate positive margins.

INNV has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 50% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Innovage Holding Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Innovage Holding Corp (INNV) Forecast

Analysts have given INNV a Hold based on their latest research and market trends.

According to 2 analysts, INNV has a Hold consensus rating as of Sep 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Innovage Holding Corp (INNV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.